Proton Radiation Therapy With Cisplatin and Etoposide Followed by Surgery in Stage III Non-Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This research study is looking at an alternative way of delivering radiation therapy with
protons. Protons are tiny particles with a positive charge that can be controlled to travel a
certain distance and stop inside the body. In theory, this allows better control of where the
radiation dose is delivered as compared to photons. Information from other research studies
suggests that proton radiation may help to reduce unwanted side effects from radiation and
allow an increase in radiation dose that increase the odds of tumor killing.
The purpose of this study is to determine the safest dose of proton radiation therapy to give
in combination with standard chemotherapy in participants with Non-Small Cell Lung Cancer
(NSCLC).